PRECISE INGREDIENTS ApS: Financial statements 2023
CVR: 27757103
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PRECISE INGREDIENTS ApS (CVR 27757103) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 597,239 and a net result of DKK 376,644 compared with DKK 268,183 the year before. That is an increase of 204.5% compared with the year before. Equity in the 2023 report amounted to DKK 952,264. The solvency ratio was 46.5%.
- Gross Profit
- DKK 597,239
- Profit/Loss
- DKK 376,644
- Equity
- DKK 952,264
- Total Assets
- DKK 2,048,065
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 597 t. | 377 t. | 952 t. | - |
| 2022 | - | 196 t. | 268 t. | 576 t. | 0 |
| 2021 | - | 196 t. | 181 t. | 307 t. | 1 |
| 2020 | - | 330 t. | 166 t. | 297 t. | 1 |
| 2019 | - | 659 t. | 181 t. | 450 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PRECISE INGREDIENTS ApS has published its annual report for 2022. Gross profit came to DKK 196,125, and the net result was DKK 268,183.
About PRECISE INGREDIENTS ApS
PRECISE INGREDIENTS ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2004. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Eli Wallin. The board consists of Eli Wallin and Jørgen Dam. The company is owned by PHARMA NORD ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,688,969 and a net result of DKK 569,700 compared with DKK 582,199 the year before. Equity in the 2025 report amounted to DKK 1,284,163.